Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | AR | P10275 | 1/20 | 0.67 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.67 |
| ▸ | XDH | P47989 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
| ▸ | PPARD | Q03181 | 2/20 | 0.53 |
| ▸ | CNR2 | P34972 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL2450520 | 0.97 | PTGS1 (0.68) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenyl Acetate SCHEMBL26667569 | 0.89 | PTGS1 (0.87) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| SCHEMBL11891610 | 0.87 | PTGS1 (0.85) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenyl Acetate SCHEMBL5138181 | 0.87 | PTGS1 (0.82) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenyl Acetate SCHEMBL29802968 | 0.83 | PTGS1 (1.00) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenyl Acetate SCHEMBL14764089 | 0.83 | PTGS1 (1.00) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenol SCHEMBL29943804 | 0.83 | ALDH1A1 (0.85) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenyl Acetate SCHEMBL112232 | 0.83 | PTGS1 (1.00) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| Eugenol SCHEMBL114133 | 0.83 | ALDH1A1 (0.85) | PTGS1ALOX5ALDH1A1CYP3A4AR | |
| SCHEMBL16679994 | 0.83 | PTGS1 (0.89) | PTGS1ALOX5ALDH1A1CYP3A4AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118948982-A | Compositions comprising alpinia and other plant extracts for improving joint health and treating arthritis | 尤尼根公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-115515614-B | Compositions comprising alpinia and other plant extracts for improving joint health and treating arthritis | 尤尼根公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-115515614-A | Compositions comprising extracts of alpinia and other plants for improving joint health and treating arthritis | 尤尼根公司 | 2022-12-23 | — | — | CN | disclosed |
| EP-2790536-A1 | DEVICE AND METHOD FOR SIMULATING CHEMOSENSATION OF SMOKING | Sentiens, LLC (US) | 2014-10-22 | — | — | EP | disclosed |
| WO-2013090410-A1 | DEVICE AND METHOD FOR SIMULATING CHEMOSENSATION OF SMOKING | SENTIENS, LLC (US) | 2013-06-20 | — | — | WO | disclosed |
| US-7629375-B2 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2009-12-08 | — | — | US | disclosed |
| EP-1694335-A4 | OSTEOCLASTOGENESIS INHIBITORS AND USES THEREOF | RES DEV FOUNDATION (US) | 2008-12-31 | — | — | EP | disclosed |
| CN-1309382-C | 1'-acetoxyl chavicol acetate with anti-HIV activity and its derivatives | HONGYI SCIENCE AND TECHNOLOGY (CN) | 2007-04-11 | — | — | CN | disclosed |
| EP-1694335-A2 | OSTEOCLASTOGENESIS INHIBITORS AND USES THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 2006-08-30 | — | — | EP | disclosed |
| US-20060178356-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | GALILEO PHARMACEUTICALS, INC. | 2006-08-10 | — | — | US | disclosed |
| WO-2006046934-A2 | OSTEOCLASTOGENESIS INHIBITORS AND USES THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 2006-05-04 | — | — | WO | disclosed |
| US-6939563-B2 | Non-fermented osmotic laxative and method for treating and preventing colorectal cancers | Inra-Institut National de la Recherche Agronomique (FR) | 2005-09-06 | — | — | US | disclosed |
| EP-1435894-A4 | CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS, AND METHODS | GALILEO PHARMACEUTICALS INC (US) | 2005-07-06 | — | — | EP | disclosed |
| US-20050142155-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | JOHNSON & JOHNSON CONSUMER INC. | 2005-06-30 | — | — | US | disclosed |
| US-20050113416-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | GALILEO PHARMACEUTICALS, INC. | 2005-05-26 | — | — | US | disclosed |
| EP-1435894-A2 | CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS, AND METHODS | Galileo Pharmaceuticals, Inc. (US) | 2004-07-14 | — | — | EP | disclosed |
| CN-1457771-A | 1'-acetoxyl chavicol acetate with anti-HIV activity and its derivatives | HONGYI SCIENCE AND TECHNOLOGY (CN) | 2003-11-26 | — | — | CN | disclosed |
| US-20030073712-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2003-04-17 | — | — | US | disclosed |
| EP-1124566-B1 | NON-FERMENTED OSMOTIC LAXATIVE FOR TREATING AND PREVENTING COLORECTAL CANCERS | AGRONOMIQUE INST NAT RECH (FR) | 2003-02-12 | — | — | EP | disclosed |
| WO-2003009807-A2 | CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS, AND METHODS | GALILEO LABORATORIES, INC. (US) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050142155-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | HSF1, HMOX1, NQO1 | PTGS1 183/4885ALOX5 131/4885ALDH1A1 488/4885 |
| US-20030073712-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | HSF1, HMOX1, NQO1 | PTGS1 183/4885ALOX5 131/4885ALDH1A1 488/4885 |
| US-20050113416-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | HSF1, HMOX1, NQO1 | PTGS1 183/4885ALOX5 131/4885ALDH1A1 488/4885 |
| US-20060178356-A1 | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods | HSF1, HMOX1, NQO1 | PTGS1 183/4885ALOX5 131/4885ALDH1A1 488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.